Most Read This Week
- Newer Pharmacologic Treatments in Adults With Type 2 Diabetes
- Effect of Combination Treatment With GLP-1 Receptor Agonists and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events
- Atypical Diabetes: What Have We Learned and What Does the Future Hold?
- Effect of SGLT2 Inhibitors on Major Adverse Cardiovascular Outcomes
- Lifetime Duration of Breastfeeding and Cardiovascular Risk in Women With Type 2 Diabetes or a History of Gestational Diabetes
Recently Updated
- Researchers Quantify the Risk for Diabetes After Gestational Diabetes
- More Than 200 Insulin Pump Users Injured After App Causes Malfunction
- Effect of Combination Treatment With GLP-1 Receptor Agonists and SGLT-2 Inhibitors on Incidence of Cardiovascular and Serious Renal Events
- Impact of Type 2 Diabetes and HbA1c Levels Within Recommended Target Range on Mortality in Older Adults With Cognitive Impairment
- Timing of Moderate to Vigorous Physical Activity, Mortality, CVD, and Microvascular Disease in Adults With Obesity